Page last updated: 2024-08-22

betamethasone-17,21-dipropionate and Cushing Syndrome

betamethasone-17,21-dipropionate has been researched along with Cushing Syndrome in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
López-Ruz, MÁ; Rosales-Castillo, A1
Aberer, W; Böckle, BC; Jara, D; Nindl, W; Sepp, NT1
Besson-Léaud, M; Dandine, M; Lavaud, J; Limal, JM1
Moriello, KA; Ridgway, HB1

Other Studies

4 other study(ies) available for betamethasone-17,21-dipropionate and Cushing Syndrome

ArticleYear
Cushing's syndrome due to interaction between topical betamethasone dipropionate and darunavir/cobicistat.
    Medicina clinica, 2020, 11-27, Volume: 155, Issue:10

    Topics: Betamethasone; Cobicistat; Cushing Syndrome; Darunavir; Humans

2020
Adrenal insufficiency as a result of long-term misuse of topical corticosteroids.
    Dermatology (Basel, Switzerland), 2014, Volume: 228, Issue:4

    Topics: Administration, Cutaneous; Adrenal Insufficiency; Adult; Betamethasone; Chronic Disease; Cushing Syndrome; Dermatitis, Atopic; Glucocorticoids; Humans; Male; Psoriasis; Self Medication; Time Factors; Young Adult

2014
[Adrenal insufficiency and iatrogenic Cushing's syndrome by cutaneous absorption of corticosteroids in an 8 month old infant].
    Annales de dermatologie et de venereologie, 1980, Volume: 107, Issue:3

    Topics: Adrenal Insufficiency; Betamethasone; Cushing Syndrome; Erythema; Female; Humans; Hydrocortisone; Iatrogenic Disease; Infant; Skin Absorption

1980
Iatrogenic Cushing's syndrome in a dog from owner's topical corticosteroid.
    Archives of dermatology, 1993, Volume: 129, Issue:3

    Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Betamethasone; Cushing Syndrome; Dog Diseases; Dogs; Glucocorticoids

1993